The single-nucleotide polymorphisms in CHD5 affect the prognosis of patients with hepatocellular carcinoma.
Zhu X, Kong Q, Xie L, Chen Z, Li H, Zhu Z, Huang Y, Lan F, Luo H, Zhan J, Ding H, Lei J, Xiao Q, Fu W, Fan W, Zhang J, Luo H.
Zhu X, et al.
Oncotarget. 2017 Dec 26;9(17):13222-13230. doi: 10.18632/oncotarget.23812. eCollection 2018 Mar 2.
Oncotarget. 2017.
PMID: 29568352
Free PMC article.